Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand

PURPOSE: Incomplete resection of prostate cancer (PCa) results in increased risk of disease recurrence. Combined fluorescence-guided surgery with tumor-targeted photodynamic therapy (tPDT) may help to achieve complete tumor eradication. We developed a prostate-specific membrane antigen (PSMA) ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Derks, Yvonne H. W., Schilham, Melline G. M., Rijpkema, Mark, Smeets, Esther M. M., Amatdjais-Groenen, Helene I. V., Kip, Annemarie, van Lith, Sanne A. M., van de Kamp, Jill, Sedelaar, J. P. Michiel, Somford, Diederik M., Simons, Michiel, Laverman, Peter, Gotthardt, Martin, Löwik, Dennis W. P. M., Heskamp, Sandra, Lütje, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317872/
https://www.ncbi.nlm.nih.gov/pubmed/37060367
http://dx.doi.org/10.1007/s00259-023-06224-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317872/
https://www.ncbi.nlm.nih.gov/pubmed/37060367
http://dx.doi.org/10.1007/s00259-023-06224-1

Ejemplares similares